earnings
confidence high
sentiment positive
materiality 0.80
McKesson Q4 adj EPS $11.69 (+16% YoY); FY2027 guidance $43.80-$44.60
MCKESSON CORP
2026-FY EPS reported
$38.38
revenue$403,430,000,000
- Q4 revenue $96.3B (+6%), full-year $403.4B (+12%); GAAP EPS $13.71, adjusted EPS $39.11 (+18% FY).
- FY2027 adjusted EPS guidance $43.80-$44.60 (12-14% growth); reaffirms long-term 13-16% target.
- Board approved $5.0B share repurchase increase (total $7.7B); $2.25B accelerated buyback entered.
- Full-year cash from operations $6.2B, free cash flow $5.4B.
- CEO cites specialty and biopharma services strength; Europe divestiture and Med-Surg separation progressing.